Electrosurgical Devices Market - Databook 2025 to 2034

The global electrosurgical devices market size accounted for USD 8.39 billion in 2024 and is predicted to touch around USD 14.17 billion by 2034, growing at a CAGR of 5.38% from 2025 to 2034.

Highlights of the Electrosurgical Devices Market

• North America dominated the global electrosurgical devices market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By product, the electrosurgical generators segment underwent notable growth in the electrosurgical devices market during 2024.
• By product, the electrodes segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By application, the general surgery segment enjoyed a prominent position in the electrosurgical devices market during 2024.
• By application, the orthopedic surgery segment is predicted to witness significant growth in the market over the forecast period.

Industry Valuation and Growth Rate Projection

The electrosurgical devices market deals with specialized machines that use high-frequency current to facilitate surgical procedures. They can cut tissue, coagulate bleeding tissue, or perform both actions in one step. One of the most significant benefits of electrosurgery is its ability to control bleeding through coagulation. The U.S. electrosurgical devices market growth is driven by the increasing geriatric population, shifting preference towards outpatient surgeries, and the increasing number of surgical procedures.

Electrosurgical Devices: Stats and Figures

• According to a report published in September 2023, the surgical patient of yesterday, today, and tomorrow: a time trend analysis based on a cohort of 8.7 million surgical patients.
• According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS) in June 2024, its Global survey on Aesthetic/Cosmetic Procedures this week at the ISAPS World Congress in Cartagena, showing a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures.

How has AI Benefited the Electrosurgical Devices Market?

Artificial intelligence (AI) can be used to augment the sharing of knowledge through the collection of massive amounts of operative video and EMR data across many surgeons. In sensitive surgical procedures, augmented reality integrated through an AI can overlay important information like vitals and hemodynamic state of a patient, in real time, to the surgeons, which may help them to improve their techniques as well as decision making during the surgery. It promotes efficiency and faster healing times, enhances accuracy and precision, personalizes patient care, and reduces complications. AI helps in surgical decision-making and reducing risk factors and human-driven errors.

Industry Leader Announcements

• Jordan Schecter, M.D., Vice President, Disease Area Leader, Multiple Myeloma, Johnson & Johnson Innovative Medicine

Jordan Schecter, M.D., Vice President, Disease Area Leader, Multiple Myeloma, Johnson & Johnson Innovative Medicine, said, “Patients with extramedullary myeloma, especially those who have exhausted prior therapies, need more effective treatment options.” “Our first in class bispecific antibodies, TALVEY and TECVAYLI, have transformed treatment for relapsed or refractory multiple myeloma. The RedirecTT-1 study underscores our commitment to advancing innovative therapies that attack the disease in different ways by building combinable and complementary regimens.

• Anita Mehta, Director of Social Impact at Stryker

Anita Mehta, Director of Social Impact at Stryker, said, “Our mission to make healthcare better cannot be achieved without our nonprofit partners.” “With each of these efforts, Stryker’s goal remains the same: we want to improve the experience of giving and receiving care, so patient outcomes improve. Our global employee base is very passionate about making a difference, and it's fantastic to see how our efforts to improve access to healthcare bring them together.”

Geographical Insights

North America dominated the global electrosurgical devices market in 2024. Rising senior population, shifting preference towards outpatient surgeries in developed regions, and rising use of minimally invasive procedures are driving the growth of the market in the North American region.

Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period. Increasing disposable income, infrastructural development, increased spending on technology, rapid industrialization and urbanization, and stringent environmental regulations are contributing to the growth of the electrosurgical devices market in the Asia Pacific region.

Recent Developments in the Electrosurgical Devices Market

• In May 2025, the VIO 3n family with a new generation of electrosurgical generators, especially tailored to different medical specialties and procedural requirements, was established by Erbe Elektromedizin GmbH.
• In March 2025, the Dualto Energy System, an electrosurgical generator that unites many energy modalities into an ‘integrated’ platform for both open and minimally invasive surgery, was launched by Johnson & Johnson (J&J) MedTech.

Competitive Landscape

• Company Name: CONMED Corporation
• Year of Incorporation: 1970
• Headquarters: Largo, Florida, near Tampa

Over 100 countries where it operates. It operates in the medical technology sector, specifically the surgical equipment and devices industry around the world.

• Company Name: Johnson & Johnson Private Ltd.
• Year of Incorporation: 1887
• Headquarters: New Brunswick, New Jersey, United States

It operates in over 60 countries. It operates in the medical sectors, specifically in Consumer Health, Medical Devices & Diagnostics, and Pharmaceuticals, around the world.